John Routes - Publications

Affiliations: 
Microbiology and Molecular Genetics Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Immunology, Cell Biology, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tallar M, Routes J. Omenn Syndrome Identified by Newborn Screening. Clinics in Perinatology. 47: 77-86. PMID 32000930 DOI: 10.1016/J.Clp.2019.09.004  0.319
2019 Bausch-Jurken MT, Hintermeyer M, Woodliff J, Chen S, Rymaszewski A, Verbsky J, Routes J. Damaging BTK Variant Demonstrated by Carrier, Allele-Specific BTK Expression in B Cells and Monocytes. Journal of Clinical Immunology. PMID 30627929 DOI: 10.1007/S10875-019-0591-6  0.311
2018 Routes J, Verbsky J. Newborn Screening for Severe Combined Immunodeficiency. Current Allergy and Asthma Reports. 18: 34. PMID 29749587 DOI: 10.1007/S11882-018-0783-9  0.311
2016 Gallagher J, Adams J, Hintermeyer M, Torgerson TR, Lopez-Guisa J, Ochs HD, Szabo S, Salib M, Verbsky J, Routes J. X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis. Journal of Clinical Immunology. PMID 27324886 DOI: 10.1007/S10875-016-0307-0  0.306
2016 Korrer MJ, Zhang Y, Routes JM. Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity. Plos One. 11: e0153122. PMID 27031640 DOI: 10.1371/Journal.Pone.0153122  0.66
2015 Korrer MJ, Routes JM. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. Results in Immunology. 5: 1-5. PMID 25685658 DOI: 10.1016/J.Rinim.2015.01.001  0.679
2014 Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, ... ... Routes J, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. Jama. 312: 729-38. PMID 25138334 DOI: 10.1001/Jama.2014.9132  0.307
2014 Routes J, Abinun M, Al-Herz W, Bustamante J, Condino-Neto A, De La Morena MT, Etzioni A, Gambineri E, Haddad E, Kobrynski L, Le Deist F, Nonoyama S, Oliveira JB, Perez E, Picard C, et al. ICON: the early diagnosis of congenital immunodeficiencies. Journal of Clinical Immunology. 34: 398-424. PMID 24619621 DOI: 10.1007/S10875-014-0003-X  0.351
2014 Korrer MJ, Routes JM. Possible role of arginase-1 in concomitant tumor immunity. Plos One. 9: e91370. PMID 24614600 DOI: 10.1371/Journal.Pone.0091370  0.687
2011 Accetta D, Syverson G, Bonacci B, Reddy S, Bengtson C, Surfus J, Harbeck R, Huttenlocher A, Grossman W, Routes J, Verbsky J. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. The Journal of Allergy and Clinical Immunology. 127: 535-538.e1-2. PMID 21167572 DOI: 10.1016/J.Jaci.2010.10.013  0.316
2011 Baker M, Atkins A, Grossman W, Seroogy C, Lindstrom M, Brokopp C, Routes J. T-cell Receptor Excision Circles of Newborns Are Associated with Gestational Age: Data from Wisconsin Newborn Screening for Severe Combined Immunodeficiency Journal of Allergy and Clinical Immunology. 127: AB146-AB146. DOI: 10.1016/J.Jaci.2010.12.578  0.315
2007 Miura TA, Cook JL, Potter TA, Ryan S, Routes JM. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity. Journal of Cellular Biochemistry. 100: 929-40. PMID 17063489 DOI: 10.1002/jcb.21057  0.335
2005 Routes JM, Ryan S, Morris K, Takaki R, Cerwenka A, Lanier LL. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. The Journal of Experimental Medicine. 202: 1477-82. PMID 16314433 DOI: 10.1084/Jem.20050240  0.352
2003 Cook JL, Miura TA, Iklé DN, Lewis AM, Routes JM. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. Cancer Research. 63: 3435-43. PMID 12810682  0.393
2001 Routes JM, Ryan JC, Ryan S, Nakamura M. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection International Immunology. 13: 1301-1307. PMID 11581175  0.318
Show low-probability matches.